Watch for Patients on the Parkinson's Med Nourianz

Istradefylline (Nourianz, NUR-ee-anz) will be the first NON-dopaminergic "adenosine antagonist" for Parkinson's disease....

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals